What is the fair value of Core Laboratories NV (NYSE-CLB) stock?

The current fair value estimate for Core Laboratories NV (NYSE-CLB) is $16.44. This implies an estimated upside of 45.5% versus the current market price.

Is Core Laboratories NV (NYSE-CLB) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 45.5% versus the current market price.

What is the analyst price target for NYSE-CLB stock?

The available analyst price target for Core Laboratories NV (NYSE-CLB) is $15.50. The analyst target implies estimated upside of 37.2%.

How is the financial health of Core Laboratories NV?

The current financial health read for Core Laboratories NV (NYSE-CLB) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Core Laboratories NV's next earnings date?

The next earnings date currently listed for Core Laboratories NV (NYSE-CLB) is July 29, 2026.

Does Core Laboratories NV (NYSE-CLB) pay dividends?

Based on the current data, dividend yield is 0.4%, upcoming dividend amount is 0.04.

What is the P/E ratio for Core Laboratories NV (NYSE-CLB)?

The current P/E ratio listed for Core Laboratories NV (NYSE-CLB) is 17.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Core Laboratories NV?

The current market capitalization listed for Core Laboratories NV is 515.8 M.

What is the enterprise value of Core Laboratories NV?

The current enterprise value listed for Core Laboratories NV is 665.7 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Core Laboratories NV?

The ticker symbol for Core Laboratories NV is NYSE-CLB, and the stock is listed on NYSE.

Where is Core Laboratories NV (NYSE-CLB) listed?

Core Laboratories NV (NYSE-CLB) is listed on NYSE.

What is the debt-to-total-capital ratio for Core Laboratories NV?

The current debt-to-total-capital ratio listed for Core Laboratories NV is 24.3%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Core Laboratories NV?

The free float listed for Core Laboratories NV is 98.6%. Free float helps investors understand how much of the share base is available for public trading.

Core Laboratories NV (CLB) Fair Value & Stock Analysis

Core Laboratories NV (CLB)

Core Laboratories NV is a common stock listing on the NYSE for a company that provides services and products to the oil and gas industry in the United States and abroad. Its activities are organized into two segments: Reservoir Description and Production Enhancement. The Reservoir Description business focuses on laboratory and field analysis of reservoir rock and fluid samples, along with studies and related services that can support oil and gas recovery, carbon capture and storage work, geothermal projects, and mining evaluations. The Production Enhancement segment supplies tools and services used in well completion, perforation, stimulation, production, and well abandonment, including diagnostic work to assess completion results and support enhanced recovery efforts. Core Laboratories was founded in 1936 and is based in Houston, Texas.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Upcoming Dividend Ex-Date	Dividend Payment Date	Upcoming Dividend	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NYSE-CLB	$16.44	45.5% Upside	Undervalued	$15.50	37.2% Upside	Undervalued	Fair	—	—	0.04	0.4%	July 29, 2026	17.7x	1.9x	1.0x	515.8 M	665.7 M	24.3%	98.6%	3.2	6.4%	63.5%

Send a message